|
1. |
α1-Proteinase Inhibitor Abrogates Proteolytic and Secretagogue Activity of Cystic Fibrosis Sputum |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 117-124
Gesine Hansen,
Antje Schuster,
Chrisiiane Zubrod,
Volker Wahn,
Preview
|
PDF (1669KB)
|
|
摘要:
Airway disease in cystic fibrosis (CF) is characterized by neutrophil-dominated chronic inflammation with an excess of uninhibited neutrophil elastase (NE), which is regarded as an important factor in progressive lung destruction. Therefore, inhalation of α1-proteinase inhibitor (α1-PI) seems to be a reasonable therapeutic approach. To estimate its therapeutic potential, we quantitatively investigated the in vitro interactions of exogenous α1-PI with CF sputum samples (n = 28). High NE and α1-PI concentrations were detected in CF sputum (6.03 ± 0.78 and 2.56 ± 0.16 µmol/l, respectively). There was significant NE activity (2.6 ± 0.4 U/l) due to both the surplus of NE and proteolytic degradation of α1-PI. Addition of exogenous α1 90% inhibition was achieved at 10 µg/ml α1-PI. Purified NE as well as CF sputum potently induced secretion from porcine tracheal glands. Corresponding to inhibition of NE activity, CF sputum-induced secretion was also inhibited by exogenous α1 90% inhibition was also achieved at 10 µg/ml α1-PI. Incubation of exogenous α1-PI with CF sputum for 24 h did not reduce the inhibitory effects. From our in vitro results we conclude that inhalation of α1-PI might effectively inhibit both NE activity and airway gland hypersecreti
ISSN:0025-7931
DOI:10.1159/000196405
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
2. |
Fibronectin and Hyaluronan in Bronchoalveolar Lavage Fluid from Young Patients with Chronic Obstructive Pulmonary Diseases |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 125-129
Wei Dong Song,
An Cheng Zhang,
Yu Ying Pang,
Li Hua Liu,
Jing Yun Zhao,
Shu Hua Deng,
Shi Yuan Zhang,
Preview
|
PDF (993KB)
|
|
摘要:
Fibronectin (FN) and hyaluronan (HA) in bronchoalveolar lavage fluid (BALF) and FN released by alveolar macrophages (AM) were examined in 7 nonsmoking healthy control subjects, and 20 smoking patients with chronic obstructive pulmonary diseases (COPD). All patients and subjects were no more than 40 years old. According to the 95 % confidence limits of HA and FN in BALF from nonsmoking healthy control subjects, the smoking patients were divided into two groups, those who had HA and FN levels within the limits for nonsmoking controls were classified as the first group (group 1) and those with levels above the control limits were classified as the second group (group 2). Our data showed that the concentrations of HA and FN in BALF and FN released by AM were significantly higher in group 2 than in group 1 patients. There were also significant differences between the two groups in pulmonary function measurements (DLCO, FEV1, and FEV1/FVC) which were lower in group 2. HA levels in group 2 patients correlated directly with counts of inflammatory cells in BALF (BALF cells/ml, and numbers/ml of total cells, macrophages, neutrophils and lymphocytes), and the concentration of FN released by AM, and showed an inverse correlation with pulmonary function (DLCO and FEV1/FVC). Our results suggest that the inflammatory repair response and fibrosis may play a role in the development of emphysema in young patients with COPD.
ISSN:0025-7931
DOI:10.1159/000196406
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
3. |
Mechanisms of 3-Carene-lnduced Bronchoconstriction in the Isolated Guinea Pig Lung |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 130-135
L. Låstbom,
A. Falk-Filipsson,
S. Boyer,
P. Moldéus,
Å. Ryrfeldt,
Preview
|
PDF (1120KB)
|
|
摘要:
Inhaled 3-carene at a concentration of 5,000 mg/m3 caused bronchoconstriction in isolated, ventilated and perfused guinea pig lungs. This effect was inhibited by the cyclooxygenase inhibitor diclofenac (100 µM) and the thromboxane/prostaglandin endoperoxide-receptor antagonist L-670,596 (1 µM). 3-Carene exposure also increased the amount of thromboxane in the perfusate from the lungs. In cultured calf pulmonary arterial endothelial cells 3-carene caused a dose-related release of arachidonic acid. Thus, the results obtained in this experimental model may have implications in the understanding of the pathophysiology of 3-carene-induced obstructive pulmonary disease in human
ISSN:0025-7931
DOI:10.1159/000196407
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
4. |
Sarcoidosis Patients Have Bronchial Hyperreactivity and Signs of Mast Cell Activation in Their Bronchoalveolar Lavage |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 136-142
Mary Berlin Öhrn,
C. Magnus Sköld,
Marianne van Hage-Hamsten,
Olöf Sigurdardottir,
Olle Zetterström,
Anders Eklund,
Preview
|
PDF (1259KB)
|
|
摘要:
An increased (p < 0.001) frequency of bronchial hyperreactivity (BHR) was found in sarcoidosis patients as compared with healthy volunteers. The patients had more mast cells (p < 0.001) and tryptase (p < 0.001) in their bronchoalveolar lavage fluid, but there were no differences between BHR-positive and BHR-negative patients. Furthermore, the bronchoalveolar lavage fluid concentrations of macrophages, lymphocytes, and of the soluble components albumin, fibronectin, and vitronectin were also elevated in the sarcoidosis patients, indicating an ongoing inflammation in the airways and/or in the interstitium. We observed no significant differences in the parameters when the sarcoidosis patients were subdivided into BHR, clinical activity, or chest X-ray stages. Our findings may indicate a multifactorial background to the hyperreactivity.
ISSN:0025-7931
DOI:10.1159/000196408
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
5. |
Intravenous Injection of Acetaldehyde But Not Ethanol Induces Histamine-Mediated Bronchoconstriction in Guinea Pigs |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 143-147
Shigeharu Myou,
Masaki Fujimura,
Motoyasu Saito,
Tamotsu Matsuda,
Preview
|
PDF (878KB)
|
|
摘要:
Recently ethanol-induced bronchoconstriction associated with elevated serum levels of acetaldehyde and histamine was reported in Japanese asthmatic patients, but there is no investigation of the airway response to intravenous injection of acetaldehyde. We therefore performed a study in guinea pigs to test the hypothesis that intravenous injection of acetaldehyde has bronchospastic action via histamine release. At first, we investigated the airway response to increasing doses (8.0, 26.4, and 80 mg/ml) of injected ethanol or acetaldehyde in guinea pigs. Secondarily, increasing doses of acetaldehyde were injected in guinea pigs pretreated with an intraperitoneal injection of 20 mg/kg diphenhydramine or saline (control). Finally, injection of acetaldehyde was performed after intraperitoneal injection of 0.5 mg/kg atropine sulfate or saline (control). Injected acetaldehyde caused bronchoconstriction in a dose-dependent manner, but ethanol did not. The bronchoconstriction induced by injected acetaldehyde was completely prevented by pretreatment with diphenhydramine. Atropine had no preventing effect against the acetaldehyde-induced bronchoconstriction. In conclusion, intravenous injection of acetaldehyde causes bronchoconstriction via histamine release in guinea pigs.
ISSN:0025-7931
DOI:10.1159/000196409
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
6. |
Stent Placement Is Justifiable in End-Stage Patients with Malignant Airway Tumours |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 148-150
G. Sutedja,
F. Schramel,
K. van Kralingen,
P.E Postmus,
Preview
|
PDF (546KB)
|
|
摘要:
Extraluminal tumour compression can be treated with the use of stenting. In 8 patients with end-stage malignant tumours of the tracheobronchial tree, tumor compression of the major airways became apparent after Nd-YAG laser debulking. Dumon-type stents (Endoxane®), were inserted under general anaesthesia. There were no complications during and after stent insertion. All stents were well tolerated, with significant symptomatic relief in all patients. This symptomatic relief was considered worthwhile, despite the limited duration of palliation and the pre-terminal stage of the patients. Tumour progression after stent insertion was usually beyond any treatment possibility, except additional laser coagulation. The median survival was 2 months and the longest palliation was 11 months
ISSN:0025-7931
DOI:10.1159/000196410
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
7. |
Tracheobronchopathia osteochondroplastica |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 151-154
Sirkku Vilkman,
Timo Keistinen,
Preview
|
PDF (594KB)
|
|
摘要:
Tracheobronchopathia osteochondroplastica (TPO) is a rare condition of unclear cause. Sporadic cases have been published from all over the world, but some geographical differences in the occurrence may exist. The condition is characterized by cartilaginous or bony outgrowths into the lumen of the tracheobronchial tree. Clinicians should include this disease in the list of differential diagnoses when confronted with symptoms like persistent and often productive cough, haemoptysis, dyspnoea and wheeze. If the condition is extensive, there may occur unexpected and acute clinical problems. We describe the case of a young man in whom we diagnosed a severe form of TPO while examining him for asthma. This patient suffered also from ozaena and the combination of these two conditions is rather common. We also retrospectively reviewed our material of 18 cases with this condition.
ISSN:0025-7931
DOI:10.1159/000196411
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
8. |
Cerebral Infarction due to a Spontaneous Tumor Embolus from Lung Cancer |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 155-156
Kazuyoshi Imaizumi,
Takanao Murate,
Joji Ohno,
Kaoru Shimokata,
Preview
|
PDF (384KB)
|
|
摘要:
A cerebral infarction of the left occipital lobe developed in a 6 5-year-old man with squamous cell carcinoma of the right lung. Neurological examinations and brain CT showed findings typical of ordinary infarction. Postmortem examination revealed a tumor embolus within the posterior cerebral artery. Such spontaneous tumor emboli large enough to obstruct a larger-sized artery are rare.
ISSN:0025-7931
DOI:10.1159/000196412
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
9. |
Exogenous Surfactant Application in Respiratory Failure due to Chronic Obstructive Pulmonary Disease |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 157-159
Hubert Wirtz,
Wolfgang Habscheid,
Georg Ertl,
Michael Schmidt,
Kurt Kochsiek,
Preview
|
PDF (583KB)
|
|
摘要:
Recent results of basic research on regulation of surfactant secretion and surfactant physiology not only in the alveolus but also in peripheral small airways allow the conclusion that disorders in surfactant homeostasis may contribute to the pathophysiology of airway obstruction and hyperinflation. We therefore hypothesized that patients with respiratory failure due to obstructive lung disease may benefit from exogenous surfactant. Here we report a case that indicates the clinical situation to be considered for treatment with exogenous surfactant. The benefit for the patient was successful weaning from the ventilator. Improvements in effective compliance, resistance and blood gas parameters were observed following surfactant application.
ISSN:0025-7931
DOI:10.1159/000196413
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
10. |
Tracheal Glomus Tumour |
|
Respiration,
Volume 62,
Issue 3,
1995,
Page 160-162
P. Arapantoni-Dadioti,
J. Panayiotides,
M. Fatsis,
G. Antypas,
Preview
|
PDF (471KB)
|
|
摘要:
A glomus tumour situated at the posterior wall of the trachea in a 65-year-old man presenting with dyspnoea and haemoptysis is described. The tumour was excised with an Nd-YAG laser, with no visible recurrence a year later. This is the fifth reported case of tracheal glomus tumour.
ISSN:0025-7931
DOI:10.1159/000196414
出版商:S. Karger AG
年代:1995
数据来源: Karger
|
|